Antifungals In Eye Infections: Drugs And Routes Of Administration

dc.creatorMuller G.G.
dc.creatorKara-Jose N.
dc.creatorDe Castro R.S.
dc.date2013
dc.date2015-06-25T19:12:47Z
dc.date2015-11-26T15:10:07Z
dc.date2015-06-25T19:12:47Z
dc.date2015-11-26T15:10:07Z
dc.date.accessioned2018-03-28T22:20:20Z
dc.date.available2018-03-28T22:20:20Z
dc.identifier
dc.identifierRevista Brasileira De Oftalmologia. , v. 72, n. 2, p. 132 - 141, 2013.
dc.identifier347280
dc.identifier10.1590/S0034-72802013000200014
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84880599448&partnerID=40&md5=bfd5e94c2334857e5edde435a3cbc02c
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/88837
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/88837
dc.identifier2-s2.0-84880599448
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1257985
dc.descriptionTreatment of fungal eye infections represents a challenge to the ophthalmology practice. For an adequate therapeutic response, besides correct drug choice, it is necessary an effectively administration. This script gathers information about the major antifungal drugs used in eye infections, their concentrations and main administration routes.
dc.description72
dc.description2
dc.description132
dc.description141
dc.descriptionLeber, T.H., Keratomycosis aspergillina als ursache von hypopyonkeratites (1879) Graefes Ach Clin Exp Ophthalmol, 25, pp. 285-301
dc.descriptionAlfonso, E.C.G.A., Miller, D., Fungal keratitis (2011) Cornea: fundamentals, diagnosis and management, , In: Krachmer JH, Mannis MJ, Holland EJ, editors.3rd ed. New York: Mosby Elsevier
dc.descriptionJones, D., Diagnosis and management of fungal keratitis Duane's clinical ophthalmology, p. 2004. , In: Tasman W, Jaeger EA, editors.Philadelphia: Lippincott Williams & Wilkins
dc.descriptionBennett, J., Agentes antimicrobianos, agentes antifúngicos (2007) As bases farmacológicas da terapêutica, pp. 1103-1117. , In: Brunton L, editor Goodman & Gilman:11a ed. Rio de Janeiro: McGraw-Hill
dc.descriptionReddy, P.R., Reddy, P.S., Reddy, A.R., Saboo, N.K., A comparative evaluation of Nystatin, Amphotericin-B and Miconazole in keratomycosis (1982) Indian J Ophthalmol, 30 (4), pp. 249-250
dc.descriptionOliveira, P.R., Resende, S.M., Oliveira, F.C., Oliveira, A.C., Ceratite fúngica (2001) Arq Bras Oftalmol, 64 (1), pp. 75-79
dc.descriptionFilippin, F.B., Souza, L.C., Eficiência terapêutica das formulações lipídicas de anfotericina B (2006) RBCF Rev Bras Ciênc Farm, 42 (2), pp. 167-194
dc.descriptionMartinez, R., Atualização no uso de agentes antifúngicos (2006) J Bras Pneumol, 32 (5), pp. 449-460
dc.descriptionGallis, H.A., Drew, R.H., Pickard, W.W., Amphotericin B: 30 years of clinical experience (1990) Rev Infect Dis, 12 (2), pp. 308-329
dc.descriptionKaur, I.P., Rana, C., Singh, H., Development of effective ocular preparations of antifungal agents (2008) J Ocul Pharmacol Ther, 24 (5), pp. 481-493. , Review
dc.descriptionKhoo, S.H., Bond, J., Denning, D.W., Administering amphotericin B-a practical approach (1994) J Antimicrob Chemother, 33 (2), pp. 203-213
dc.descriptionMora-Duarte, J., Betts, R., Rotstein, C., Colombo, A.L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Perfect, J., Caspofungin Invasive Candidiasis Study Group.Comparison of caspofungin and amphotericin B for invasive candidiasis (2002) N Engl J Med, 347 (25), pp. 2020- 9. , Comment in N Engl J Med. 2002;347(25):2070-2. ACP J Club. 2003;139(1):15. N Engl J Med. 2003;348(13):1287-8
dc.descriptionauthor reply 1287-8
dc.descriptionShirley, S.F., Little, J.R., Immunopotentiating effects of amphotericin B (1979) I.Enhanced contact sensitivity in mice. J Immunol., 123 (6), pp. 2878-2882
dc.descriptionShirley, S.F., Little, J.R., Immunopotentiating effects of amphotericin B (1979) II Enhanced in vitro proliferative responses of murine lymphocytes. J Immunol., 123 (6), pp. 2883-2889
dc.descriptionGreen, W.R., Bennett, J.E., Goos, R.D., Ocular penetration of amphotericin B: a report of laboratory studies and a case report of postsurgical cephalosporium endophthalmitis (1965) Arch Ophthalmol, 73, pp. 769-775
dc.descriptionGoldblum, D., Frueh, B.E., Zimmerli, S., Böhnke, M., Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex (2000) Cornea, 19 (6), pp. 853-856
dc.descriptionO'Day, D.M., Head, W.S., Robinson, R.D., Stern, W.H., Freeman, J.M., Intraocular penetration of systemically administered antifungal agents (1985) Curr Eye Res, 4 (2), pp. 131-134. , Erratum in: Curr Eye Res 1986;5(7):547
dc.descriptionQu, L., Li, L., Xie, H., Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model (2010) Ophthalmic Res, 43 (3), pp. 153-158
dc.descriptionPleyer, U., Grammer, J., Pleyer, J.H., Kosmidis, P., Friess, D., Schmidt, K.H., Thiel, H.J., Studies with local administration of liposome incorporated amphotericin (1995) Amphotericin B-bioavailability in the cornea Ophthalmologe, 92 (4), pp. 469-475. , German
dc.descriptionO'Day, D.M., Head, W.S., Robinson, R.D., Clanton, J.A., Corneal penetration of topical amphotericin B and natamycin (1986) Curr Eye Res, 5 (11), pp. 877-882
dc.descriptionO'Day, D.M., Ray, W.A., Head, W.S., Robinson, R.D., Influence of the corneal epithelium on the efficacy of topical antifungal agents (1984) Invest Ophthalmol Vis Sci, 25 (7), pp. 855-859
dc.descriptionHirose, H., Terasaki, H., Awaya, S., Yasuma, T., Treatment of fungal corneal ulcers with amphotericin B ointment (1997) Am J Ophthalmol, 124 (6), pp. 836-838
dc.descriptionWood, T.O., Williford, W., Treatmen of keratomycosis with amphotericin B 015% (1976) Am J Ophthalmol., 81 (6), pp. 847-849
dc.descriptionO'Day, D.M., Selection of appropriate antifungal therapy (1987) Cornea, 6 (4), pp. 238-245. , Review
dc.descriptionO'Day, D.M., Ray, W.A., Robinson, R.D., Head, W.S., Williams, T.E., Differences in response in vivo to amphotericin B among Candida albicans strains (1991) Invest Ophthalmol Vis Sci, 32 (5), pp. 1569-1572
dc.descriptionGarcia-Valenzuela, E., Song, C.D., Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis (2005) Arch Ophthalmol, 123 (12), pp. 1721-1723
dc.descriptionKermani, N.K., Aggarwal, S.P., Isolated post-operative Aspergillus niger endophthalmitis (2000) Eye (Lond), 14 (PART 1), pp. 114-116
dc.descriptionYoon, K.C., Jeong, I.Y., Im, S.K., Chae, H.J., Yang, S.Y., Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis (2007) Cornea, 26 (7), pp. 814-818
dc.descriptionKaushik, S., Ram, J., Brar, G.S., Jain, A.K., Chakraborti, A., Gupta, A., Intracameral amphotericin B: initial experience in severe keratomycosis (2001) Cornea, 20 (7), pp. 715-719
dc.descriptionKuriakose, T., Kothari, M., Paul, P., Jacob, P., Thomas, R., Intracameral amphotericin B injection in the management of deep keratomycosis (2002) Cornea, 21 (7), pp. 653-656
dc.descriptionYilmaz, S., Ture, M., Maden, A., Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis (2007) Cornea, 26 (4), pp. 398-402
dc.descriptionPerraut, L.E., Perraut, L.E., Bleiman, B., Lyons, J., Successful treatment of Candida albicans endophthalmitis with intravitreal amphotericin B (1981) Arch Ophthalmol, 99 (9), pp. 1565-1567
dc.descriptionSerracarbassa, P.D., Peyman, G.A., Liang, C., Calixto, N., Nair, M.G., Toxicity and efficacy of intravitreal injection of spartanamicin B in the treatment of Candida endophthalmitis (1998) Int Ophthalmol, 22 (1), pp. 53-58
dc.descriptionMascaro, V.L.D.M., Höfling-Lima, A.L., Gompertz, O.F., Yu, M.C.Z., Matta, D.A., Colombo, A.L., Antifungal susceptibility testing of yeast isolated from corneal infections (2003) Arq Bras Oftalmol, 66 (5), pp. 647-652
dc.descriptionMattia, A., Cerniglia, C., Baines, J., Safety evaluation of certain food additives and contaminants Natamycin, , http://www.inchem.org/documents/jecfa/jecmono/v48je06.htm, Pimaricin WHO Food Additives Series: 48.Available from
dc.descriptionTu, E.Y., McCartney, D.L., Beatty, R.F., Springer, K.L., Levy, J., Edward, D., Successful treatment of resistant ocular fusariosis with posaconazole (2007) Am J Ophthalmol, 143 (2), pp. 222-227. , SCH-56592
dc.descriptionJones, D.B., Sexton, R., Rebell, G., Mycotic keratitis in South Florida: a review of thirty-nine cases (1970) Trans Ophthalmol Soc U K, 89, pp. 781-797
dc.descriptionPanda, A., Sharma, N., Das, G., Kumar, N., Satpathy, G., Mycotic keratitis in children: epidemiologic and microbiologic evaluation (1997) Cornea, 16 (3), pp. 295-299
dc.descriptionRosa, R.H., Miller, D., Alfonso, E.C., The changing spectrum of fungal keratitis in south Florida (1994) Ophthalmology, 101 (6), pp. 1005-1013
dc.descriptionOliveira, L.A., Takata, T.T., Shiguematsu, A.I., Júnior, M.L.A., Gompertz, O.F., Sousa, L.B., Mannis, M.J., Effect of topical 0.5% povidone-iodine compared to 5% natamycin in fungal keratitis caused by Fusarium solani in a rabbit model: a pilot study (2008) Arq Bras Oftalmol, 71 (6), pp. 860-864
dc.descriptionPrajna, N.V., Mascarenhas, J., Krishnan, T., Reddy, P.R., Prajna, L., Srinivasan, M., Comparison of natamycin and voriconazole for the treatment of fungal keratitis (2010) Arch Ophthalmol, 128 (6), pp. 672-678. , Comment in Arch Ophthalmol. 2011;129(6):814
dc.descriptionauthor reply 814-5
dc.descriptionPrajna, N.V., John, R.K., Nirmalan, P.K., Lalitha, P., Srinivasan, M., A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis (2003) Br J Ophthalmol, 87 (10), pp. 1235-1237
dc.descriptionDursun, D., Fernandez, V., Miller, D., Alfonso, E.C., Advanced fusarium keratitis progressing to endophthalmitis (2003) Cornea, 22 (4), pp. 300-303
dc.descriptionTanure, M.A., Cohen, E.J., Sudesh, S., Rapuano, C.J., Laibson, P.R., Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania (2000) Cornea, 19 (3), pp. 307-312
dc.descriptionKalavathy, C.M., Parmar, P., Kaliamurthy, J., Philip, V.R., Ramalingam, M.D., Jesudasan, C.A., Thomas, P.A., Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis (2005) Cornea, 24 (4), pp. 449-452
dc.descriptionKlont, R.R., Eggink, C.A., Rijs, A.J., Wesseling, P., Verweij, P.E., Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole (2005) Clin Infect Dis, 40 (12), pp. e110-2
dc.descriptionLalitha, P., Shapiro, B.L., Srinivasan, M., Prajna, N.V., Acharya, N.R., Fothergill, A.W., Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis (2007) Arch Ophthalmol, 125 (6), pp. 789-793
dc.descriptionLi, L., Wang, Z., Li, R., Luo, S., Sun, X., In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients (2008) Am J Ophthalmol, 146 (5), pp. 724-728
dc.descriptionXuguang, S., Zhixin, W., Zhiqun, W., Shiyun, L., Ran, L., Ocular fungal isolates and antifungal susceptibility in northern China (2007) Am J Ophthalmol, 143 (1), pp. 131-133
dc.descriptionPearce, J.W., Giuliano, E.A., Moore, C.P., In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole (2009) Vet Ophthalmol, 12 (5), pp. 318-324
dc.descriptionJones, D.B., Forster, F.K., Rebell, G., Fusarium solani keratitis treated with natamycin (pimaricin): eighteen consecutive cases (1972) Arch Ophthalmol, 88 (2), pp. 147-154
dc.descriptionPolack, F.M., Kaufman, H.E., Newmark, E., Keratomycosis.Medical and surgical treatment (1971) Arch Ophthalmol, 85 (4), pp. 410-416
dc.descriptionAmaral, V.C.S., Junior, N.G.P., Ketoconazole- and fluconazole-induced embryotoxicity and skeletal anomalies in wistar rats: a comparative study (2008) Braz Arch Biol Technol, 51 (6), pp. 1153-1161
dc.descriptionSawyer, P.R., Brogden, R.N., Pinder, R.M., Speight, T.M., Avery, G.S., Miconazole: a review of its antifungal activity and therapeutic efficacy (1975) Drugs, 9 (6), pp. 406-423
dc.descriptionColey, K.C., Crain, J.L., Miconazole-induced fatal dysrhythmia (1997) Pharmacotherapy, 17 (2), pp. 379-382
dc.descriptionBarasch, A., Griffin, A.V., Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials (2008) Future Microbiol, 3 (3), pp. 265-269
dc.descriptionFothergill, A.W., Miconazole: a historical perspective (2006) Expert Rev Anti Infect Ther, 4 (2), pp. 171-175
dc.descriptionKobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., Watanabe, N., Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect (2002) Antimicrob Agents Chemother, 46 (10), pp. 3113-3117
dc.descriptionThevissen, K., Ayscough, K.R., Aerts, A.M., Du, W., De Brucker, K., Meert, E.M., Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast (2007) J Biol Chem, 282 (30), pp. 21592-7
dc.descriptionSud, I.J., Feingold, D.S., Mechanisms of action of the antimycotic imidazoles (1981) J Invest Dermatol, 76 (6), pp. 438-441
dc.descriptionFoster, C.S., Stefanyszyn, M., Intraocular penetration of miconazole in rabbits (1979) Arch Ophthalmol, 97 (9), pp. 1703-1706
dc.descriptionMohan, M., Panda, A., Gupta, S.K., Management of human keratomycosis with miconazole (1989) Aust N Z J Ophthalmol, 17 (3), pp. 295-297
dc.descriptionFitzsimons, R., Peters, A.L., Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis (1986) Am J Ophthalmol, 101 (5), pp. 605-608
dc.descriptionGupta, S.K., Efficacy of miconazole in experimental keratomycosis (1986) Aust N Z J Ophthalmol, 14 (4), pp. 373-376
dc.descriptionFoster, C.S., Miconazole therapy for keratomycosis (1981) Am J Ophthalmol, 91 (5), pp. 622-629
dc.descriptionIshibashi, Y., Kaufman, H.E., The effects of subconjunctival miconazole in the treatment of experimental Candida keratitis in rabbits (1985) Arch Ophthalmol, 103 (10), pp. 1570-1573
dc.descriptionThomas, P.A., Current perspectives on ophthalmic mycoses (2003) Clin Microbiol Rev, 16 (4), pp. 730-797
dc.descriptionUchida, K., Abe, S., Yamaguchi, H., The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida Species (2006) Microbiol Immunol, 50 (9), pp. 679-685
dc.descriptionHeel, R.C., Brogden, R.N., Speight, T.M., Avery, G.S., Econazole: a review of its antifungal activity and therapeutic efficacy (1978) Drugs, 16 (3), pp. 177-201
dc.descriptionMahashabde, S., Nahata, M.C., Shrivastava, U., A comparative study of anti-fungal drugs in mycotic corneal ulcer (1987) Indian J Ophthalmol, 35 (5-6), pp. 149-152
dc.descriptionIshibashi, Y., Oral ketoconazole therapy for keratomycosis (1983) Am J Ophthalmol, 95 (3), pp. 342-345
dc.descriptionThomas, P.A., Kalavathy, C.M., Abraham, D.J., Rajasekaran, J., Oral ketoconazole in Keratomycosis (1987) Indian J Ophthalmol, 35 (4), pp. 197-203
dc.descriptionIshibashi, Y., Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis (1986) Am J Ophthalmol, 102 (4), pp. 547-548
dc.descriptionTorres, M.A., Mohamed, J., Cavazos-Adame, H., Martinez, L.A., Topical ketoconazole for fungal keratitis (1985) Am J Ophthalmol, 100 (2), pp. 293-298
dc.descriptionKomadina, T.G., Wilkes, T.D., Shock, J.P., Ulmer, W.C., Jackson, J., Bradsher, R.W., Treatment of Aspergillus fumigatus keratitis in rabbits with oral and topical ketoconazole (1985) Am J Ophthalmol, 99 (4), pp. 476-479
dc.descriptionSingh, S.M., Khan, R., Sharma, S., Chatterjee, P.K., Clinical and experimental mycotic corneal ulcer caused by Aspergillus fumigatus and the effect of oral ketoconazole in the treatment (1989) Mycopathologia, 106 (3), pp. 133-141
dc.descriptionMarangon, F.B., Miller, D., Giaconi, J.A., Alfonso, E.C., In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens (2004) Am J Ophthalmol, 137 (5), pp. 820-825
dc.descriptionRajasekaran, J., Thomas, P.A., Kalavathy, C.M., Joseph, P.C., Abraham, D.J., Itraconazole therapy for fungal keratitis (1987) Indian J Ophthalmol, 35 (5-6), pp. 157-160
dc.descriptionAbad, J.C., Foster, C.S., Fungal keratitis (1996) Int Ophthalmol Clin, 36 (3), pp. 1- 15. , Review
dc.descriptionKlotz, S.A., Zahid, M., Bartholomew, W.R., Revera, P.M., Butrus, S., Candida albicans keratitis treated successfully with itraconazole (1996) Cornea, 15 (1), pp. 102-104
dc.descriptionO'Day, D.M., Foulds, G., Williams, T.E., Robinson, R.D., Allen, R.H., Head, W.S., Ocular uptake of fluconazole following oral administration (1990) Arch Ophthalmol, 108 (7), pp. 1006-1008
dc.descriptionThakar, M., Oral fluconazole therapy for keratomycosis (1994) Acta Ophthalmol (Copenh), 72 (6), pp. 765-767
dc.descriptionUrbak, S.F., Degn, T., Fluconazole in the management of fungal ocular infections (1994) Ophthalmologica, 208 (3), pp. 147-156
dc.descriptionMahdy, R.A., Nada, W.M., Wageh, M.M., Kader, M.A., Saleh, M.M., Alswad, M.M., Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis (2010) Cutan Ocul Toxicol, 29 (3), pp. 193-197
dc.descriptionYilmaz, S., Maden, A., Severe fungal keratitis treated with subconjunctival fluconazole (2005) Am J Ophthalmol, 140 (3), pp. 454-458. , Comment in Am J Ophthalmol. 2006;141(4):783
dc.descriptionauthor reply 783-4
dc.descriptionMahdy, R.A., Nada, W.M., Wageh, M.M., Topical amphotericin B and subconjunctival injection of fluconazole combination therapy versus topical amphotericin B monotherapy in treatment of keratomycosis (2010) J Ocul Pharmacol Ther, 26 (3), pp. 281-285
dc.descriptionYee, R.W., Cheng, C.J., Meenakshi, S., Ludden, T.M., Wallace, J.E., Rinaldi, M.G., Ocular penetration and pharmacokinetics of topical fluconazole (1997) Cornea, 16 (1), pp. 64-71. , Comment in Cornea. 1997;16(6):700
dc.descriptionAvunduk, A.M., Beuerman, R.W., Warnel, E.D., Kaufman, H.E., Greer, D., Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis (2003) Curr Eye Res, 26 (2), pp. 113-117
dc.descriptionDotto, P.F., Rodrigues, L.D., Fernandes, M.L.B., Figueira, B.B.D., Takahashi, W.Y., Carani, J.C., Serracarbassa, P.D., Uso do fluconazol endovenoso no tratamento da endoftalmite fúngica endógena: relato de caso (2005) Arq Bras Oftalmol, 68 (4), pp. 543-546
dc.descriptionChristmas, N.J., Smiddy, W.E., Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis (1996) Ophthalmic Surg Lasers, 27 (12), pp. 1012-1018
dc.descriptionWellington, M., Gigliotti, F., Update on antifungal agents (2001) Pediatr Infect Dis J, 20 (10), pp. 993-995
dc.descriptionHariprasad, S.M., Mieler, W.F., Lin, T.K., Sponsel, W.E., Graybill, J.R., Voriconazole in the treatment of fungal eye infections: a review of current literature (2008) Br J Ophthalmol, 92 (7), pp. 871-878
dc.descriptionHerbrecht, R., Denning, D.W., Patterson, T.F., Bennett, J.E., Greene, R.E., Oestmann, J.W., Kern, W.V., Pauw, P.B., Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis (2002) N Engl J Med, 347 (6), pp. 408- 15. , Comment in N Engl J Med. 2002;347(25):2080-1
dc.descriptionauthor reply 2080-1. N Engl J Med. 2002;347(25):2080-1
dc.descriptionauthor reply 2080-1. N Engl J Med. 2004;350(9):950-2
dc.descriptionFreda, R., Use of oral voriconazole as adjunctive treatment of severe cornea fungal infection: case report (2006) Arq Bras Oftalmol, 69 (3), pp. 431-434
dc.descriptionHariprasad, S.M., Mieler, W.F., Holz, E.R., Gao, H., Kim, J.E., Chi, J., Prince, R.A., Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans (2004) Arch Ophthalmol, 122 (1), pp. 42-47
dc.descriptionGao, H., Pennesi, M., Shah, K., Qiao, X., Hariprasad, S.M., Mieler, W.F., Safety of intravitreal voriconazole: electroretinographic and histopathologic studies (2003) Trans Am Ophthalmol Soc, 101, pp. 183-189. , discussion 189
dc.descriptionAnderson, K.L., Mitra, S., Salouti, R., Pham, T.A., Taylor, H.R., Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair (2004) Cornea, 23 (5), pp. 516-521
dc.descriptionBunya, V.Y., Hammersmith, K.M., Rapuano, C.J., Ayres, B.D., Cohen, E.J., Topical and oral voriconazole in the treatment of fungal keratitis (2007) Am J Ophthalmol, 143 (1), pp. 151-153
dc.descriptionLee, S.J., Lee, J.J., Kim, S.D., Topical and oral voriconazole in the treatment of fungal keratitis (2009) Korean J Ophthalmol, 23 (1), pp. 46-48
dc.descriptionNulens, E., Eggink, C., Rijs, A.J., Wesseling, P., Verweij, P.E., Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole (2003) J Clin Microbiol, 41 (5), pp. 2261-2264
dc.descriptionPolizzi, A., Siniscalchi, C., Mastromarino, A., Saccà, S.C., Effect of voriconazole on a corneal abscess caused by fusarium (2004) Acta Ophthalmol Scand, 82 (6), pp. 762-764
dc.descriptionAl-Badriyeh, D., Neoh, C.F., Stewart, K., Kong, D.C., Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis (2010) Clin Ophthalmol, 4, pp. 391-405
dc.descriptionDupuis, A., Tournier, N., Moal, L.G., Venisse, N., Preparation and stability of voriconazole eye drop solution (2009) Antimicrob Agents Chemother, 53 (2), pp. 798-799
dc.descriptionClode, A.B., Davis, J.L., Salmon, J., Michau, T.M., Gilger, B.C., Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses (2006) Am J Vet Res, 67 (2), pp. 296-301
dc.descriptionPrakash, G., Sharma, N., Goel, M., Titiyal, J.S., Vajpayee, R.B., Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis (2008) Am J Ophthalmol, 146 (1), pp. 56-59
dc.descriptionSiatiri, H., Daneshgar, F., Siatiri, N., Khodabande, A., The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis (2011) Cornea, 30 (8), pp. 872-875
dc.descriptionSharma, N., Agarwal, P., Sinha, R., Titiyal, J.S., Velpandian, T., Vajpayee, R.B., Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series (2011) Br J Ophthalmol, 95 (12), pp. 1735-1737
dc.descriptionGiaconi, J.A., Marangon, F.B., Miller, D., Alfonso, E.C., Voriconazole and fungal keratitis: a report of two treatment failures (2006) J Ocul Pharmacol Ther, 22 (6), pp. 437-439
dc.descriptionDiekema, D.J., Messer, S.A., Hollis, R.J., Jones, R.N., Pfaller, M.A., Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi (2003) J Clin Microbiol, 41 (8), pp. 3623-3626
dc.descriptionJohnson, L.B., Kauffman, C.A., Voriconazole: a new triazole antifungal agent (2003) Clin Infect Dis, 36 (5), pp. 630-637
dc.descriptionEspinel-Ingroff, A., Boyle, K., Sheehan, D.J., In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature (2001) Mycopathologia, 150 (3), pp. 101-115
dc.descriptionMarco, F., Pfaller, M.A., Messer, S.A., Jones, R.N., Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi (1998) Med Mycol, 36 (6), pp. 433-436
dc.descriptionUllmann, A.J., Cornely, O.A., Burchardt, A., Hachem, R., Kontoyiannis, D.P., Töpelt, K., Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection (2006) Antimicrob Agents Chemother, 50 (2), pp. 658-666
dc.descriptionCuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Buitrago, M.J., Monzon, A., Rodriguez-Tudela, J.L., Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi (2006) Antimicrob Agents Chemother, 50 (3), pp. 917-921
dc.descriptionTorres, H.A., Hachem, R.Y., Chemaly, R.F., Kontoyiannis, D.P., Raad, I.I., Posaconazole: a broad-spectrum triazole antifungal (2005) Lancet Infect Dis, 5 (12), pp. 775-785
dc.descriptionSponsel, W.E., Graybill, J.R., Nevarez, H.L., Dang, D., Ocular and systemic posaconazole(SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis (2002) Br J Ophthalmol, 86 (7), pp. 829-830
dc.descriptionVermes, A., Guchelaar, H.J., Dankert, J., Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions (2000) J Antimicrob Chemother, 46 (2), pp. 171-179
dc.descriptionMabon, M., Fungal keratitis (1998) Int Ophthalmol Clin, 38 (4), pp. 115-123
dc.descriptionMorris, M.I., Villmann, M., Echinocandins in the management of invasive fungal infections, part 1 (2006) Am J Health Syst Pharm, 63 (18), pp. 1693-1703. , Review
dc.descriptionMorris, M.I., Villmann, M., Echinocandins in the management of invasive fungal infections, Part 2 (2006) Am J Health Syst Pharm, 63 (19), pp. 1813-1820. , Review
dc.descriptionBachmann, S.P., VandeWalle, K., Ramage, G., Patterson, T.F., Wickes, B.L., Graybill, J.R., López-Ribot, J.L., In vitro activity of caspofungin against Candida albicans biofilms (2002) Antimicrob Agents Chemother, 46 (11), pp. 3591-3596
dc.descriptionWagner, C., Graninger, W., Presterl, E., Joukhadar, C., The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications (2006) Pharmacology, 78 (4), pp. 161-177. , Review
dc.descriptionGoldblum, D., Frueh, B.E., Sarra, G.M., Katsoulis, K., Zimmerli, S., Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model (2005) Antimicrob Agents Chemother, 49 (4), pp. 1359-1363
dc.descriptionMatsumoto, Y., Dogru, M., Goto, E., Fujishima, H., Tsubota, K., Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review (2005) Cornea, 24 (6), pp. 748-753
dc.descriptionMatsumoto, Y., Murat, D., Kojima, T., Shimazaki, J., Tsubota, K., The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis (2011) Br J Ophthalmol, 95 (10), pp. 1406-1409
dc.descriptionBennett, J.E., Dismukes, W.E., Duma, R.J., Medoff, G., Sande, M.A., Gallis, H., A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis (1979) N Engl J Med, 301 (3), pp. 126-131
dc.descriptionArora, I., Kulshrestha, O.P., Upadhaya, S., Treatment of fungal corneal ulcers with econazole (1983) Indian J Ophthalmol, 31 (SUPPL), pp. 1019-1021
dc.descriptionSugar, A.M., Use of amphotericin B with azole antifungal drugs: what are we doing (1995) Antimicrob Agents Chemother, 39 (9), pp. 1907-1912
dc.descriptionCacciapuoti, A., Gurnani, M., Halpern, J., Norris, C., Patel, R., Loebenberg, D., Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo (2005) Antimicrob Agents Chemother, 49 (2), pp. 638-642
dc.descriptionNajvar, L.K., Cacciapuoti, A., Hernandez, S., Halpern, J., Bocanegra, R., Gurnani, M., Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories (2004) Antimicrob Agents Chemother, 48 (3), pp. 758-764. , Comment in Antimicrob Agents Chemother. 2004;48(8):3211
dc.descriptionauthor reply 3211-2
dc.descriptionLin, H.C., Chu, P.H., Kuo, Y.H., Shen, S.C., Clinical experience in managing Fusarium solani keratitis (2005) Int J Clin Pract, 59 (5), pp. 549-554
dc.descriptionRoth, N.P.A., Ba, E.A., Wane, A.M., Meideros, D.M., Dieng, M., Ka, A., Fungal keratitis in an intertropical area: diagnosis and treatment problems (2006) Advantage of local use of polyvidone iodine J Fr Ophtalmol, 29 (8), p. 19. , French
dc.descriptionFiscella, R.G., Moshifar, M., Messick, C.R., Pendland, S.L., Chandler, J.W., Viana, M., Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis (1997) Cornea, 16 (4), pp. 447-449
dc.descriptionO'Day, D.M., Ray, W.A., Head, W.S., Robinson, R.D., Williams, T.E., Influence of corticosteroid on experimentally induced keratomycosis (1991) Arch Ophthalmol, 109 (11), pp. 1601-1604
dc.descriptionShi, W., Wang, T., Xie, L., Li, S., Gao, H., Liu, J., Li, H., Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation (2010) Ophthalmology, 117 (5), pp. 890-896
dc.languageen
dc.publisher
dc.relationRevista Brasileira de Oftalmologia
dc.rightsaberto
dc.sourceScopus
dc.titleAntifungals In Eye Infections: Drugs And Routes Of Administration
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución